Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chemical Research in Toxicology

• Publication date

  2009-05-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/tx900031zPMID 19408964PMCID PMC2819755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases

  2008cited by this paper
• Identification of Hydroxywarfarin Binding Site in Human UDP Glucuronosyltransferase 1A10: Phenylalanine90 Is Crucial for the Glucuronidation of 6- and 7-Hydroxywarfarin but Not 8-Hydroxywarfarin

  2008cited by this paper
• Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants

  2008cited by this paper
• Pharmacogenomics of 4-hydroxycoumarin anticoagulants.

  2008cited by this paper
• A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.

  2008cited by this paper
• The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics

  2008cited by this paper
• Synthesis and structure-activity relationships of novel warfarin derivatives.

  2007cited by this paper
• Mass spectrometry-based metabolomics.

  2007cited by this paper
• Comparison of the inhibition effect of different anticoagulants on vitamin K epoxide reductase activity from warfarin-susceptible and resistant rat

  2007cited by this paper
• Association of warfarin dose with genes involved in its action and metabolism

  2006cited by this paper
• Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.

  2000cited by this paper
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

  1996cited by this paper
• Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.

  1996cited by this paper
• Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.

  1995cited by this paper
• Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.

  1993cited by this paper
• Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.

  1992cited by this paper
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.

  1992cited by this paper
• Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide.

  1984cited by this paper
• A comparison of the isomers of warfarin

  1966cited by this paper

• A model-based analysis of the CYP2C9 genotype effects on fluconazole inhibition using flurbiprofen, ketoprofen and tolbutamide as probe drugs.

  2026cites this paper
• Personalized Medicine Approach to Proteomics and Metabolomics of Cytochrome P450 Enzymes: A Narrative Review

  2024cites this paper
• Development of a rapid HPLC-fluorescence method for monitoring warfarin metabolites formation: In vitro studies for evaluating the effect of piperine on warfarin metabolism and plasma coagulation

  2024cites this paper
• Effect of High Altitude Environment on Pharmacokinetic and Pharmacodynamic of Warfarin in Rats.

  2024cites this paper
• Automated warfarin dose prediction for Asian, American, and Caucasian populations using a deep neural network

  2023cites this paper
• Simultaneous Characterization and Determination of Warfarin and Its Hydroxylation Metabolites in Rat Plasma by Chiral Liquid Chromatography-Tandem Mass Spectrometry

  2022influential citation
• Pharmacokinetic Modeling of Warfarin І – Model-Based Analysis of Warfarin Enantiomers with a Target Mediated Drug Disposition Model Reveals CYP2C9 Genotype-Dependent Drug-Drug Interactions of S-Warfarin

  2022cites this paper
• Pharmacokinetic Modeling of Warfarin ІI – Model-Based Analysis of Warfarin Metabolites after Warfarin Administered Either Alone or Together with Fluconazole or Rifampin

  2022cites this paper
• Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism

  2022cites this paper
• Biofabrication of synthetic human liver tissue with advanced programmable functions

  2022cites this paper
• Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin

  2022cites this paper
• A novel, rapid and simple UHPLC-MS/MS method for quantification of warfarin in dried blood spots.

  2022cites this paper
• Predicting Range of Initial Warfarin Dose Based on Pharmacometabolomic and Genetic Inputs

  2021influential citation
• Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition.

  2019cites this paper
• Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin

  2019cites this paper
• Genome‐wide expression reveals multiple systemic effects associated with detection of anticoagulant poisons in bobcats (Lynx rufus)

  2018cites this paper
• Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients

  2018cites this paper
• Detection of the anticoagulant drug warfarin by palladium complexes.

  2017cites this paper
• Enzyme-catalyzed Michael addition for the synthesis of warfarin and its determination via fluorescence quenching of l-tryptophan.

  2017cites this paper
• CYP2C9 Genotype‐Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R‐ and S‐Warfarin and Their Oxidative Metabolites

  2017cites this paper
• Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine.

  2016cites this paper
• Comparison of enzyme kinetics of warfarin analyzed by LC-MS/MS QTrap and differential mobility spectrometry.

  2016cites this paper
• Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS

  2016cites this paper
• Agilent LC / Q-TOF and Mass MetaSite Software for Seamless Metabolite Identifi cation Application Note

  2015cites this paper
• Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats.

  2015cites this paper
• Simultaneous and stereospecific analysis of warfarin oxidative metabolism using 2D LC/Q-TOF.

  2015cites this paper
• Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.

  2015cites this paper
• Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.

  2014cites this paper
• Carbonyl reduction pathways in drug metabolism

  2014cites this paper
• The Impact of R10-Hydroxywarfarin on CYP2C9-Mediated S-Warfarin Metabolism

  2014cites this paper
• An electrochemical sensor based on multiwall carbon nanotubes and molecular imprinting strategy for warfarin recognition and determination

  2014cites this paper
• Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

  2013cites this paper
• Investigation of the safety of topical metronidazole from a pharmacokinetic perspective.

  2013cites this paper
• Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

  2013cites this paper
• Analysis of R- and S-Hydroxywarfarin Glucuronidation Catalyzed by Human Liver Microsomes and Recombinant UDP-Glucuronosyltransferases

  2012cites this paper
• Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos.

  2012cites this paper
• The use of warfarin therapy following cardioversion

  2012cites this paper
• Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin.

  2011cites this paper
• Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

  2011cites this paper
• Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.

  2011cites this paper
• Comparative metabolism of warfarin in rats and chickens.

  2011cites this paper
• Resistance to Fusarium head blight and seedling blight in wheat is associated with activation of a cytochrome p450 gene.

  2010cites this paper
• Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

  2010cites this paper
• Metabolic profiling of HepG2 cells incubated with S(−) and R(+) enantiomers of anti-coagulating drug warfarin

  2010cites this paper
• Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug‐metabolizing cytochrome P450 enzymes

  2010cites this paper
• Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

  2009cites this paper
• Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

  2009cites this paper